{
"NDC": {
"NDCCode": "12714-196-50",
"PackageDescription": "50 mg in 1 VIAL, SINGLE-DOSE (12714-196-50) ",
"NDC11Code": "12714-0196-50",
"ProductNDC": "12714-196",
"ProductTypeName": "DRUG FOR FURTHER PROCESSING",
"ProprietaryName": null,
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Idarucizumab",
"DosageFormName": "LIQUID",
"RouteName": null,
"StartMarketingDate": "20151021",
"EndMarketingDate": null,
"MarketingCategoryName": "DRUG FOR FURTHER PROCESSING",
"ApplicationNumber": null,
"LabelerName": "Boehringer Ingelheim Pharma GmbH and Co. KG",
"SubstanceName": "IDARUCIZUMAB",
"StrengthNumber": "50",
"StrengthUnit": "mg/50mg",
"Pharm_Classes": null,
"DEASchedule": null,
"Status": "Unfinished",
"LastUpdate": "2023-05-04",
"PackageNdcExcludeFlag": null,
"ProductNdcExcludeFlag": null,
"ListingRecordCertifiedThrough": "20241231",
"StartMarketingDatePackage": "21-OCT-15",
"EndMarketingDatePackage": null,
"SamplePackage": null
}
}